Funding {4}
FOUNDER
This trial is an investigator-initiated trial which is funded by a National Health Research Projects with the identifier PI21/01590. The founder did not have any role in the design of the study and will not have any role in collection, analysis, and interpretation of data and in writing the manuscript.The funding period includes 1 January 2022 to 31 December 2024.